检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:周围[1] 周恩相 王泽强[1] 陈洲熙[1] 郭琼[1] 廖妮[1] 丁祖炎
机构地区:[1]湖南省株洲市一医院乳腺外科,湖南株州412000 [2]湖南湘雅二医院乳腺甲状腺外科,湖南长沙410011 [3]湖南省株州市一医院病理科,湖南株州412000
出 处:《现代肿瘤医学》2011年第2期279-283,共5页Journal of Modern Oncology
摘 要:目的:研究抗凋亡基因(Survivin)、环氧化酶-2(COX-2)和碱性成纤维细胞生长因子(bFGF)在正常乳腺组织、乳腺良性疾病和乳腺癌组织中的表达及其相关性。方法:用免疫组化方法检测10例正常乳腺组织、45例乳腺良性疾病和60例乳腺癌中Survivin、COX-2和bFGF的表达,并分析其与乳腺癌的临床病理特征的相关性。结果:Survivin、COX-2和bFGF在良性乳腺疾病及与乳腺癌组织中的表达相比均有显著差异。Survivin、Cox-2和bFGF的表达都与乳腺癌淋巴结转移和TNM病理分期显著相关。结论:Survivin、COX-2在乳腺癌中的表达明显高于正常乳腺和良性乳腺疾病。bFGF在乳腺癌中的表达高于良性乳腺疾病。Sur-vivin、COX-2和bFGF可能在乳腺癌的发生、生长和转移中起重要作用,其中COX-2和bFGF可能起协同作用,而Survivin则是三者中相对独立的一种因子。Objective:To study the expression of Survivin, cyclooxgenase - 2 (COX -2) and basic fibroblast growth factor (bFGF) in normal breast epithelia, benign breast disease and breast cancer and their relationship. Methods: Normal breast epithelia( n = 10) , benign breast disease ( n = 45 ) and breast cancer ( n = 60) were ana- lyzed for Survivin, COX - 2 and bFGF expression by immunohistochemistry technique. Results : Survivin was expressed in 73.33% in breast cancer. COX - 2 was expressed in 53.3% in breast cancer, bFGF was 41.7% in breast cancer. They were significantly different from the expression in benign breast disease ( P 〈 0.05 ). Survivin, COX - 2 and bFGF expression were correlated with TNM stage, lymph mode metastasis ( P 〈 0.05 ). Conclusion : The expression of Survivin and COX -2 in breast cancer are higher than those in normal breast epithelia and benign breast disease . The expression of bFGF in breast cancer is higher than that in benign breast disease . Survivin COX -2 and bFGF probably play an important role in the tumorigenesis, development and metastasis of breast cancer. The effect of COX - 2 and bFGF are probably co - operation each other.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.80